Mining Proxy Logs: Finding Needles In Haystacks - Department of Energy
hypertension needles, haystacks - Viapath7) Professor...Journal of Computational Physics. DOI:...
Transcript of hypertension needles, haystacks - Viapath7) Professor...Journal of Computational Physics. DOI:...
‘Screening for ‘causes’ of
hypertension – needles, haystacks
& mass spec(ulation)?’
Hypertension in the blood - & urine..?
Prof Kennedy Cruickshank
Cardiovascular Medicine & Diabetes
Nutritional Sciences Division
King’s College &
King’s Health Partners (St Thomas’/Guy’s Hosps), UK
London (with Univ. West Indies, Jamaica & Barbados,
Cameroon, Nigeria, Ghana & New Orleans, USA).
N. Xiao, J.D. Humphrey, C.A. Figueroa. "Multi-Scale Computational Model of Three-
Dimensional Hemodynamics within a Deformable Full-Body Arterial Network."
Journal of Computational Physics. DOI: 10.1016/j.jcp.2012.09.016
Variation in
Flow and Pressure
across the
Arterial tree..
(modelled) Note resulting
Pulse Wave
Velocity
changes
(estimated) Courtesy of
Dr A Figueroa,
King’s College
Alteration in arterial parameter
Number of CV events
Arterial biomarker of CV events :
Intermediate end-point
Longitudinal study
Eg:
Pulse wave velocity (PWV)
Central (aortic) BP
Augmentation ?
CVD death rates by Systolic Blood
Pressure
0
50
100
150
200
250
300
<120 120-
139
140-
159
160-
179
180-
199
>200
Systolic BP level (mmHg)
Dea
th r
ate
s p
er 1
0,0
00
perso
n-y
rs
without diabetes
with diabetes
Age adjusted cardiovascular death rates
with and without diabetes at screening
for MRFIT
Alive Died
80 220 4
25
130 160 190
Pu
lse
Wa
ve
Vel
oci
ty (
m/s
)
Arterial Stiffness as Pulse Wave
Velocity (PWV) vs SBP for all
T2 Diabetes & GTTd Controls
Vacarro et al 2003 Cruickshank et al Circulation 2002
Systolic BP mmHg
NB: Accord Trial data 2010
Individual Patient Meta-analysis of Arterial
Stiffness and Mortality – an intermediary
outcome not a risk factor..
Ben-Shlomo et al, JACC 2014
0
10
20
30
40 %
< 50 60 70 80 90 100 110 120 130 140
Diastolic Blood Pressure mmHg
Manchester 23 Jamaica 15 Cameroon – urban 4.4
% BP (treated)
Cameroon – rural 0.5
Age-adjusted blood pressure distributions of
west African-origin populations
Cruickshank et al, J Hypert 2001; 19: 41-46
Barker hypothesis
• Fetal origins of Adult CVS Disease*
• Consistent, global association of poor fetal growth
Low Birth weight Disproportional
thin baby poor placenta
• ? Nutritional inadequacy
* Barker DJP. Mothers, babies & Disease in later
life. BMJ books, London 1998.
Weight Gain from Birth to 3 months
& Rise in Systolic BP
Bansal et al, J Hypert 2008; 26 (3): 412-18
‘Tracking’ coefficients of children blood pressure: the Brompton study, UK
De Swiet et al, BMJ 1992; 304:23-26
100
105
110
115
120
systo
lic B
P (
mm
Hg
)
■ 13.1 - 18.8 kg/m² ♦ 18.8 - 21.9 kg/m² ● 21.9 - 39.5 kg/m²
White Black
Caribbean
Black
African
Indian Pakistani/
Bangladeshi
MixedWhite
Other
UK: systolic BP by BMI tertiles among adolescent girls
The MRC DASH Study in London Schools
Harding, Maynard, Cruickshank, J Hypertension 2006
Ingrid A. Tennant, Debbie S. Thompson,, Alan T. Barnett, Jan Kips*, M Boyne, E Chung, A Chung, C Osmond#, MA. Hanson, PD Gluckman,
P Segers*, J Kennedy Cruickshank, Terrence E. Forrester
Univ. West Indies Mona Jamaica
Univs. Ghent, Belgium, & Southampton, King’s College London, UK
11
Cardiovascular structure and function
in adult survivors of severe acute
malnutrition
Hypertension – accepted May 2014
Differences in cardiovascular measures (SD
scores) between controls vs. all SAM survivors
12
Measurement
(standardised score)
Controls – all SAM survivors
Difference 95%CI, p-value
Controlled for age and sex
Systolic blood pressure -0.22 -0.55 to 0.12, 0.2
Diastolic blood pressure -0.40 -0.71 to -0.08, 0.02 Heart rate 0.21 -0.14 to 0.56, 0.2
Pulse Wave Velocity 0.35 0.06 to 0.65, 0.02
Stroke Volume 0.49 0.15 to 0.82, 0.005
Cardiac Output 0.56 0.23 to 0.90, 0.001
Ejection Fraction -0.41 -0.76 to -0.06, 0.02
LV outflow tract diameter 0.71 0.39 to 1.03, <0.001
Systemic Vascular Resistance -0.69 -1.03 to -0.35, <0.001 LV Mass index -0.02 -0.35 to 0.31, 0.9
Central Systolic BP -0.15 -0.47 to 0.18, 0.4
Hypertension – accepted May 2014
X 2
Expected
NB
Temperature
difference
Initial studies of Arterial function in
Ghana
Factors related to PWV (arterial stiffness) in T2 Diabetes patients
with (n=164) and without ‘High BP’ (n=83), in hypertensives
(n= 78), & in similarly aged Controls (n=62)
Standardised
B
P value
Mean BP 0.38 <0.001
Age 0.34 <0.001
Hypertension status 0.196 0.001
BMI -0.172 0.001
Diabetes status 0.126 0.025
WHR 0.035 0.4
Heart rate 0.035 0.4
FPG 0.016 0.8 Yeboah, Govoni,
JKC, Amoah
‘Diagnosis’ of Hypertension
‘the level of BP above which treatment
does more good than harm’
(Rose 1964)
= need Randomised Clinical Trials of
TREATMENT to decide
Hypertension currently...
• >140/90 mmHg (30+% adults – BUT age-related)
• 98% Primary (essential)
• 2% Secondary: Adrenal gland tumours /
hyperplasia [?]
• Kidney disease
• Renal artery stenosis
• Genetic disorders
• Drugs (OCP) Liquorice
Candidate genes screened for linkage
to (high) BP in African-
Americans, Caribbeans and west Africans:
• Epith. Na+ channel
•TGF- B
• Endothelin-1, Naturetic peptides
• a- receptors
• Glyc389 B1 Rc
• Aldosterone synthase
• NO synthase
• Angiotensinogen etc.
All linked, & not found on repeat sampling in other data.
cf. UK MRC’s ‘BRIGHT’ study
Sick genes, Sick individuals or
Sick populations with chronic
disease? An example from studying
diabetes & hypertension in African-
origin populations.
Kennedy Cruickshank
with J-C Mbanya, R Wilks, B Balkau,
N McF Anderson & T Forrester
Int J Epidemiol 2001; 30: 111-117
What it’s all about is
regulation of gene expression
–
not the genome itself
Primary Hyperaldosteronism (Kaplan NM: In Kaplan’s Clinical Hypertension 2002)
= Conn’s syndrome
- 70% adrenal hyperplasia
- V. rarely adrenal carcinoma
- glucocorticoid suppressible aldosteronism (autosomal dominant)
• Low Prevalence (1-2% of unselected hypertensives)
30% caused by
adrenal adenoma
• Adenomata commoner in women (rare in children)
Adrenal enlargement
‘Normal’ adrenal ‘limbs’ <5mm Johnson et al
Frequency of aldosteronism in
hypertension:
4.8% Aldosterone Producing Adenoma
6.4% Idiopathic Hyperaldosteronism
0
20
40
60
80
100
120
1955 1965 1975 1985 1995
Primary Aldosteronism -- Mayo Clinic
No. of New Cases/yr
Conn’s
syndrome
Spironolactone
discovered
ARR first used
Algorithm for diagnosis and management of PA
CT adrenals (fine
cuts)
Normal OR
Micronodule(s)<1cm
Mass >1cm
Adrenal
Vein
Sampling
Medical
treatmentUnilateral
adrenalectomy
*Suspicious of
adenomatous
PA?
No
lateralizationLateralization
BILATERAL
ADRENAL
HYPERPLASIA
UNILATERAL
PRIMARY
ALDOSTERONISM
Age >40
Age <40
*Clinical features which make adenomatous Primary Aldosteronism
more likely include: hypokalemia / severe hypertension / younger age
/high levels of aldosterone
Part 2-Establish subtype of PA
Morris Brown’s ‘breakthrough’
Variants of aldosterone-producing
adenomas: classical Conn’s may be
tip of the iceberg
.
Brown M J Hypertension. 2014;63:24-26
Azizan E.. Brown MJ. APAs Nat Gen 2013
Azizan E.. Brown MJ. APAs Nat Gen 2013
Functional consequences of somatic mutants in Aldo-p Adenomas
Unusual ‘pure ZG’ Adenoma
Original CT
PET
Overlay
Coronal - PET
‘Searching for Adenomas…’
- Mr KA, 47y; Ghanaian-origin
(via Morris Brown)
Le profilage des stéroïdes d’urine
Courtesy of Dr Norman Taylor
Urinary steroids & Arterial stiffness
Courtesy of Dr Norman Taylor & Ms D Bobeica
r = 0.47,
P=0.02
N= 24
Summary
• Arterial function a genuine candidate
beyond high BP
• Think ‘life-course’ not just ‘adults’
• Gene variants not seriously implicated
for the great majority of HIGH BP
• Aldosteronism.. Moving forwards..?! –
- still not common but..